MANAGE NISSANKA: Open Payments
NPI 1477535540 · SOUTH WINDSOR, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 15 payments from 7 companies in 2025. Trend: 2023 $690 · 2024 $1,187 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $368 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $284 |
| Neurocrine BioSciences, Inc. | 2 | $249 |
| Axsome Therapeutics, Inc. | 2 | $234 |
| Alkermes, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
Products named: CAPLYTA, INGREZZA, REXULTI, Auvelity, ARISTADA, ABILIFY MAINTENA, COBENFY, INVEGA SUSTENNA.
Industry payments across CT — which companies pay providers there.
